Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering.
BioVie shares dipped 41.8% to $1.10 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Ainos, Inc. (NASDAQ: AIMD) gained 112.3% to $2.23 in pre-market trading.
- MSP Recovery, Inc. (NASDAQ: LIFW) shares rose 41.7% to $1.46 in pre-market trading. LifeWallet announced a comprehensive settlement with 28 affiliated property and casualty insurers, benefiting LifeWallet’s medicare clients across the U.S.
- Jaguar Health, Inc. (NASDAQ: JAGX) shares rose 37.8% to $0.1220 in pre-market trading after surging 50% on Friday.
- Renalytix Plc (NASDAQ: RNLX) gained 35.5% to $1.41 in pre-market trading. Renalytix recently announced that effective March 1, 2024, the United States Government has approved adding the company’s FDA de Novo Marketing authorized test, kidneyintelX.dkd, to its 10-year Governmentwide Acquisition Contract for early-stage kidney disease bioprognostic testing services.
- Aadi Bioscience, Inc. (NASDAQ: AADI) shares surged 20.8% to $2.32 in pre-market ...